Janith A. Seneviratne

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability

Zsuzsanna Nagy, Janith A. Seneviratne, Maxwell Kanikevich et al. · Nature Communications · 2021 · 83 citations · Full text

Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory

Xiaojun Yuan, Janith A. Seneviratne, Shibei Du et al. · Cell Reports · 2022 · 49 citations · Full text

Peripheral Neuroblastic Tumors, Engineering, Tumor Innervation +20

Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells

Julie A.I. Thoms, Peter Truong, Shruthi Subramanian et al. · Blood · 2021 · 40 citations

Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface

Jessica Koach, Jessica K. Holien, Hassina Massudi et al. · Cancer Research · 2019 · 33 citations · Full text

A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma

Belamy B. Cheung, Ane Kleynhans, Rituparna Mittra et al. · Oncogene · 2021 · 26 citations · Full text